← Eichor
Study identifier: NCT05895045 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Yoga for Treatment of Overactive Bladder in Pediatric Patients

Condition: Overactive Bladder · Overactive Bladder Syndrome · Overactive Detrusor  ·  Sponsor: Duke University

PhaseNA
Planned participants40
Who can joinAll sexes, 8 Years to 18 Years
Healthy volunteersNo

About this study

The goal of this pilot study is to assess the impact of yoga as a treatment modality in pediatric patients age 8-18 diagnosed with idiopathic overactive bladder as measured by validated questionnaires and urinary biomarkers. The main question it aims to answer is: Does yoga help improve overactive bladder symptoms in this patient population? Participants will take part in a weekly yoga session for a total of 6 weeks with validated questionnaires and urinary samples for biomarkers to be completed at the beginning, middle and end of the study. This study will follow a cross-over study design and patients will receive standard of care while not in the active treatment arm.

This description comes directly from the study's public registry record.

Talk to the study team

Rafael Tua-Caraccia, MD  ·  7865546150  ·  rdt25@duke.edu

Jonathan Routh, MD, MPH  ·  (919) 684-6994  ·  jonathan.routh@duke.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Duke University HospitalDurham, North Carolina, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05895045